Prostate-specific antigen as a screening test for prostate cancer: The United States experience

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 299-306

  Arcangeli, C G ^a   Ornstein, D K ^a   Keetch, D W ^a   Andriole, G L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN; TERAZOSIN;

AGE; BLOOD LEVEL; CANCER MORTALITY; CANCER SCREENING; EARLY DIAGNOSIS; HUMAN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; UNITED STATES;

EID: 0030994031     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70376-1     Document Type: Article

References (82)

1. T.S. Bates J.M. Reynard T.J. Peters Determination of prostatic volume with transrectal ultrasound: A study of intra-observer and inter-observer variation J Urol 155 1996 1299
2. M. Bazinet F. Peloquin A. Meshref Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma Urology 43 1994 44
3. M.C. Benson I.S. Whang A. Pantuck Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 147 1992 815
4. J.G. Borer J. Sherman M.C. Solomon Age-specific reference ranges for prostate specific antigen and digital rectal examination may not safely eliminate further diagnostic procedures J Urol 155 1996 322A
5. M.K. Brawer P.H. Lange Prostate-specific antigen: Its role in early detection, staging, and monitoring patients with prostatic carcinoma J Endourol 3 1989 227
6. M.K. Brawer E.A.G. Aramburu G.L. Chen The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma J Urol 150 1993 369
7. M.K. Brawer M.P. Chetner J. Beatie Screening for prostate carcinoma with prostate specific antigen J Urol 147 1992 841
8. J.A. Brown D.D. Peterson M.M. Lieber Terazosin and finasteride both lower serum prostate-specific antigen (PSA) level in men with benign prostatic hyperplasia (BPH) J Urol 155 1996 424A
9. P.S. Bunting A guide to the interpretation of serum prostate specific antigen levels Clin Biochem 28 1995 221
10. H.B. Carter J.D. Pearson E.J. Metter Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease JAMA 267 1992 2215
11. W.J. Catalona J.W. Colberg D.S. Smith Measurement of percent-free PSA improves specificity for lower PSA cutoffs in prostate cancer screening J Urol 155 1996 422A
12. W.J. Catalona M.A. Hudson P.T. Scardino Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: Receiver operating characteristic curves J Urol 152 1994 2037
13. W.J. Catalona J.P. Richie F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283
14. W.J. Catalona J.P. Richie J.B. de Kernion Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves J Urol 152 1994 2031
15. W.J. Catalona D.S. Smith T.L. Ratliff Detection of organ-confined prostate cancer is increased through prostate-specific antigen based screening JAMA 270 1993 948
16. W.J. Catalona D.S. Smith T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156
17. W.J. Catalona D.S. Smith R.L. Wolfert Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening JAMA 274 1995 1214
18. G.W. Chodak P. Keller H.W. Schoenberg Assessment of screening for prostate cancer using the digital rectal examination J Urol 141 1989 1136
19. A. Christensson C.B. Laurell H. Lilja Enzymatic activity of the prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors Eur J Biochem 194 1990 755
20. A. Christensson T. Bjork O. Nilsson Serum prostate specific antigen complexed to α 1-antichymotrypsin as an indicator of prostate cancer J Urol 150 1993 100
21. J.W. Colberg D.S. Smith W.J. Catalona Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng/ml J Urol 149 1993 507
22. M.S. Cookson M.K. Floyd T.P. Ball Jr The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels J Urol 154 1995 1070
23. W.H. Cooner B.R. Mosley C.L. Rutherford Jr Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen J Urol 143 1990 1146
24. T. Demura N. Shinohara M. Tanaka Ratio of free and total prostate specific antigen: A method of detecting prostate cancer in the cases with PSA levels of 10 ng/ml or lower J Urol 155 1996 368A
25. A.A. Elgamal F. Cornillie H. van Poppel Free/total PSA ratio (F/T) as a single test for detection of significant T1C prostate cancer J Urol 155 1996 369A
26. J.I. Epstein P.C. Walsh M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
27. C.L. Ercole P.H. Lange M. Mathisen Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer J Urol 138 1987 1181
28. J. Franklin L.S. Marks F. Dorey Serum PSA levels following TURP in men with BPH: Long term characterization J Urol 155 1996 378A
29. P.J. Gann C.H. Hennekens M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 1995 289
30. W.J. Glenski G.G. Klee E.J. Bergstralh Prostate specific antigen: Establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations Prostate 21 1992 99
31. M. Graefen P. Hammerer P. Henke Percentage of free PSA does not correlate with pathological outcome J Urol 155 1996 370A
32. H.A. Guess G.J. Gormley E. Stoner The effect of finasteride on prostate specific antigen: Review of available data J Urol 155 1996 3
33. D.A. Guthman E.J. Bergstralh T.M. Wilson Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level: Prevalence and pathologic characteristics Urology 42 1993 150
34. P. Hammerer H. Huland Systematic sextant biopsies in 651 patients referred for prostate evaluation J Urol 151 1994 99
35. Y. Hasui K. Marutsuka Y. Asada Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia Prostate 25 1994 91
36. J.D. Herschman D.S. Smith W.J. Catalona Effect of ejaculation on free and total PSA levels J Urol 155 1996 423A
37. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate specific antigen in patients with prostate cancer J Urol 142 1989 1011
38. P.A. Humphrey D.W. Keetch D.S. Smith Prospective characterization of pathologic features of prostate carcinomas detected via serum prostate specific antigen-based screening J Urol 155 1996 816
39. D.W. Keetch W.J. Catalona D.S. Smith Serial prostatic biopsies in men with persistently elevated PSA values J Urol 151 1994 1571
40. D.W. Keetch J. McMurtry D.S. Smith PSA density versus PSA slope as predictors of prostate cancer in patients with initially negative biopsies J Urol 156 1996 428 431
41. F. Labrie A. Dupont R. Suburu Serum prostate specific antigen as prescreening test for prostate cancer J Urol 147 1992 846
42. H. Lilja T. Bjork P.A. Abrahamsson Improved separation between normals, benign prostatic hyperplasia (BPH) and carcinoma of the prostate (CAP) by measuring free (F), complexed (C) and total concentrations (T) of prostate specific antigen (PSA) J Urol 151 1994 400A
43. H. Lilja A. Christensson U. Dahlen Prostate-specific antigen in human serum occurs predominantly in complex with alpha antichymotrypsin Clin Chem 37 1991 1618
44. A.A. Luderer Y.T. Chen T.F. Soriano Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen Urology 46 1995 187
45. K. Mandel A.W. Partin G. Hill PSA density in BPH: Correlation with stroma-epithelial ratios and influence of age J Urol 149 1993 448A
46. J.K. McAleer L.W. Gerson D. McMAhon Effect of digital rectal examination (and ejaculation) on serum prostate-specific antigen after 24 hours Urology 41 1993 111
47. C. Mettlin G.W. Jones G.P. Murphy Trends in prostate care in the United States, 1974–1990: Observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer CA Cancer J Clin 43 1993 83
48. C. Mettlin F. Lee J. Drago Findings on the detection of early prostate cancer in 2425 men Cancer 67 1991 2949
49. C. Mettlin P.J. Littrup R.A. Kane Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared to age-referenced PSA, PSA density, and PSA change Cancer 74 1994 1615
50. C. Mettlin G.P. Murphy F. Lee Characteristics of prostate cancers detected in a multimodality early detection program Cancer 72 1993 1701
51. C. Mettlin G.P. Murphy F. Lee Characteristics of prostate cancer detected in the American Cancer Society–National Prostate Cancer Detection Project J Urol 152 1994 1737
52. M.I. Miller A.E. Katz E. Ikeguchi Patient outcome when free:total (F:T) PSA, PSA density and PSA velocity are utilized to improve serum PSA specificity J Urol 155 1996 369A
53. T.O. Morgan D.G. McLeod J.W. Moul Clinical use of free PSA to avoid repeat prostate biopsy in men with elevated total PSA J Urol 155 1996 370A
54. R.B. Nadler P.A. Humphrey D.S. Smith Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels J Urol 154 1995 407
55. J.E. Oesterling S.J. Jacobsen W.H. Cooner The use of age-specific reference ranges for serum prostate specific antigen in men 60 years or older J Urol 153 1995 1160
56. J.E. Oesterling S.J. Jacobsen C.G. Chute Serum prostate specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges JAMA 270 1993 860
57. J.E. Oesterling V.J. Suman H. Zincke PSA-detected (clinical stage T1c or BO) prostate cancer: Pathologically significant tumors Urol Clin North Am 20 1993 687
58. J.E. Oesterling K.J. Wojno B. England A comparison of free to total PSA (F/T) ratio to total PSA for distinguishing benign prostatic hyperplasia (BPH) from prostate cancer (CaP) using the Abbott AxSYM system J Urol 155 1996 370A
59. M. Ohori T.M. Wheeler J.K. Dunn The pathological features and prognosis of prostate cancer detectable with current diagnostic tests J Urol 152 1994 1714
60. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747
61. A.W. Partin E.N.P. Subong K.A. Jones Free/total PSA does not improve the prediction of final pathological stage for men with localized prostate cancer J Urol 155 1996 415A
62. F after radical prostatectomy J Urol 155 1996 416A
63. A. Reissigl H. Klocker J. Pointner Improvement of prostate cancer (PCA) screening by determination of the ratio free/total (f/t) PSA in addition to PSA levels: A prospective study J Urol 155 1996 370A
64. F.M. Rommell V.E. Agusta J.A. Breslin Use of prostate-specific antigen and prostate-specific antigen density in diagnosis of prostate cancer in community based urology practice J Urol 151 1994 88
65. A.I. Sagalowsky F.H. Wiams I. Jialal Ability of the ratio between free and total prostate specific antigen (PSA) and different PSA assays to predict ultimate histological diagnosis of prostatic tissue J Urol 155 1996 420A
66. S. Saito C. Ozu K. Nakamura Screening of prostate cancer with free and total prostate specific antigen (PSA) ratio J Urol 155 1996 373A
67. R. Scaletscky M.O. Koch C.W. Eckstein Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen J Urol 152 1994 129
68. E. Seaman M. Whang C.A. Olsson PSA density (PSAD), role in patient evaluation and management Urol Clin North Amer 20 1993 653
69. R. Simak S. Madersbacher Z.F. Zhang The impact of ejaculation on serum prostate-specific antigen J Urol 150 1993 895
70. D.S. Smith W.J. Catalona Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection J Urol 152 1994 1163
71. D.S. Smith W.J. Catalona The nature of prostate cancer detected through prostate specific antigen based screening J Urol 152 1994 1732
72. D.S. Smith W.J. Catalona D.W. Keetch Comparison of percent free PSA and PSA density as methods to enhance the specificity of PSA screening J Urol 155 1996 422A
73. T.A. Stamey A.F. Prestigiacomo Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng/ml range in male volunteers J Urol 155 1996 1977
74. T.A. Stamey N. Yang A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909
75. 1-antichymotrypsin before diagnosis of prostate cancer Lancet 344 1994 1594
76. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer Cancer Res 51 1991 222
77. R.A. Stephenson C.R. Smart B.C. James The fall in incidence of prostate cancer (CaP): On the down side of a PSA detection/screening induced peak in incidence—data from the Utah Tumor registry J Urol 153 1995 416A
78. 0 or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentration Urology 41 1993 3
79. I.M. Thompson J.J. Ernst M.P. Gangai Adenocarcinoma of the prostate: Results of routine urological screening J Urol 132 1984 690
80. M.-B. Tchetgen J.T. Song M. Strawderman Ejaculation increases the serum prostate-specific antigen concentration Urology 47 1996 511
81. G. Vallancien D. Prapotnich B. Veillon Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination J Urol 146 1991 1308
82. J.J.J. Yuan D.E. Coplen J.A. Petros Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels J Urol 147 1992 810